{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:21:57Z","timestamp":1794900117457,"version":"4.9.1"},"reference-count":85,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA240625"],"award-info":[{"award-number":["R37CA240625"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA259111"],"award-info":[{"award-number":["R01CA259111"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM133332"],"award-info":[{"award-number":["T32GM133332"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014008","name":"Ovarian Cancer Research Alliance","doi-asserted-by":"publisher","award":["MIG-2023-2-1018"],"award-info":[{"award-number":["MIG-2023-2-1018"]}],"id":[{"id":"10.13039\/100014008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>p16 is a tumor suppressor encoded by the CDKN2A gene whose expression is lost in approximately 50% of all human cancers. In its canonical role, p16 inhibits the G1\u2013S-phase cell cycle progression through suppression of cyclin-dependent kinases. Interestingly, p16 also has roles in metabolic reprogramming, and we previously published that loss of p16 promotes nucleotide synthesis via the pentose phosphate pathway. However, the broader impact of p16\/CDKN2A loss on other nucleotide metabolic pathways and potential therapeutic targets remains unexplored. Using CRISPR knockout libraries in isogenic human and mouse melanoma cell lines, we determined several nucleotide metabolism genes essential for the survival of cells with loss of p16\/CDKN2A. Consistently, many of these genes are upregulated in melanoma cells with p16 knockdown or endogenously low CDKN2A expression. We determined that cells with low p16\/CDKN2A expression are sensitive to multiple inhibitors of de novo purine synthesis, including antifolates. Finally, tumors with p16 knockdown were more sensitive to the antifolate methotrexate in vivo than control tumors. Together, our data provide evidence to reevaluate the utility of these drugs in patients with p16\/CDKN2Alow tumors as loss of p16\/CDKN2A may provide a therapeutic window for these agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Antimetabolites were the first chemotherapies, yet many have failed in the clinic due to toxicity and poor patient selection. Our data suggest that p16 loss provides a therapeutic window to kill cancer cells with widely-used antifolates with relatively little toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0450","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:22:36Z","timestamp":1713280956000},"page":"1174-1188","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["<i>De Novo<\/i>\n                    Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9153-5825","authenticated-orcid":true,"given":"Naveen Kumar","family":"Tangudu","sequence":"first","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-6666","authenticated-orcid":true,"given":"Raquel","family":"Buj","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1418-4658","authenticated-orcid":true,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8500-1197","authenticated-orcid":true,"given":"Jiefei","family":"Wang","sequence":"additional","affiliation":[{"name":"2Department of Biomedical Informatics and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-0848","authenticated-orcid":true,"given":"Aidan R.","family":"Cole","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8037-9676","authenticated-orcid":true,"given":"Apoorva","family":"Uboveja","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9559-9735","authenticated-orcid":true,"given":"Richard","family":"Fang","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2856-1446","authenticated-orcid":true,"given":"Amandine","family":"Amalric","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0333-5144","authenticated-orcid":true,"given":"Baixue","family":"Yang","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."},{"name":"3Tsinghua University School of Medicine, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-9527","authenticated-orcid":true,"given":"Adam","family":"Chatoff","sequence":"additional","affiliation":[{"name":"4Department of Cardiovascular Sciences, Aging + Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-1568","authenticated-orcid":true,"given":"Claudia V.","family":"Crispim","sequence":"additional","affiliation":[{"name":"4Department of Cardiovascular Sciences, Aging + Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-7481","authenticated-orcid":true,"given":"Peter","family":"Sajjakulnukit","sequence":"additional","affiliation":[{"name":"5Department of Molecular and Integrative Physiology, Department of Internal Medicine, Division of Gastroenterology, and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9070-9445","authenticated-orcid":true,"given":"Maureen A.","family":"Lyons","sequence":"additional","affiliation":[{"name":"6Genomics Facility, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-1648","authenticated-orcid":true,"given":"Kristine","family":"Cooper","sequence":"additional","affiliation":[{"name":"7Biostatistics Facility, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-8783","authenticated-orcid":true,"given":"Nadine","family":"Hempel","sequence":"additional","affiliation":[{"name":"8Division of Hematology\/Oncology, Department of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-6141","authenticated-orcid":true,"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[{"name":"5Department of Molecular and Integrative Physiology, Department of Internal Medicine, Division of Gastroenterology, and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0817-9880","authenticated-orcid":true,"given":"Uma R.","family":"Chandran","sequence":"additional","affiliation":[{"name":"2Department of Biomedical Informatics and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-8747","authenticated-orcid":true,"given":"Nathaniel W.","family":"Snyder","sequence":"additional","affiliation":[{"name":"4Department of Cardiovascular Sciences, Aging + Cardiovascular Discovery Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-2325","authenticated-orcid":true,"given":"Katherine M.","family":"Aird","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"2024050214014116200_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/35096061","article-title":"The INK4a\/ARF network in tumour suppression","volume":"2","author":"Sherr","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2024050214014116200_bib2","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res"},{"key":"2024050214014116200_bib3","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/sj.onc.1202918","article-title":"Functional evaluation of tumour-specific variants of p16INK4a\/CDKN2A: correlation with protein structure information","volume":"18","author":"Ruas","year":"1999","journal-title":"Oncogene"},{"key":"2024050214014116200_bib4","doi-asserted-by":"crossref","first-page":"10.15761\/CRR.1000145","DOI":"10.15761\/CRR.1000145","article-title":"Aberrant expression of p16(INK4a) in human cancers \u2013 a new biomarker?","volume":"2","author":"Inoue","year":"2018","journal-title":"Cancer Rep Rev"},{"key":"2024050214014116200_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.94.2.669","article-title":"Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF","volume":"94","author":"Quelle","year":"1997","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2024050214014116200_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jid.2022.07.016","article-title":"Therapeutic strategies for targeting CDKN2A loss in melanoma","volume":"143","author":"Kreuger","year":"2023","journal-title":"J Invest Dermatol"},{"key":"2024050214014116200_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","article-title":"Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"EBioMedicine"},{"key":"2024050214014116200_bib8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/cells10061334","article-title":"CDK4\/6 inhibitors in melanoma: a comprehensive review","volume":"10","author":"Garutti","year":"2021","journal-title":"Cells"},{"key":"2024050214014116200_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41698-022-00273-9","article-title":"Harnessing the immunotherapeutic potential of CDK4\/6 inhibitors in melanoma: is timing everything?","volume":"6","author":"Lelliott","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"2024050214014116200_bib10","doi-asserted-by":"crossref","first-page":"e1677140","DOI":"10.1080\/23723556.2019.1677140","article-title":"p16: cycling off the beaten path","volume":"6","author":"Buj","year":"2019","journal-title":"Mol Cell Oncol"},{"key":"2024050214014116200_bib11","article-title":"ATR promotes mTORC1 activation via de novo cholesterol synthesis in p16-low cancer cells","author":"Tangudu","year":"2023","journal-title":"bioRxiv"},{"key":"2024050214014116200_bib12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.celrep.2019.07.084","article-title":"Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming","volume":"28","author":"Buj","year":"2019","journal-title":"Cell Rep"},{"key":"2024050214014116200_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fonc.2018.00015","article-title":"DNA damage, repair, and cancer metabolism","volume":"8","author":"Turgeon","year":"2018","journal-title":"Front Oncol"},{"key":"2024050214014116200_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2014.01.017","article-title":"Nucleotide metabolism, oncogene-induced senescence and cancer","volume":"356","author":"Aird","year":"2015","journal-title":"Cancer Lett"},{"key":"2024050214014116200_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.trecan.2023.04.008","article-title":"Emerging roles of nucleotide metabolism in cancer","volume":"9","author":"Shi","year":"2023","journal-title":"Trends Cancer"},{"key":"2024050214014116200_bib16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.tcb.2023.03.003","article-title":"Regulation of nucleotide metabolism in cancers and immune disorders","volume":"33","author":"Ali","year":"2023","journal-title":"Trends Cell Biol"},{"key":"2024050214014116200_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fendo.2018.00177","article-title":"Deoxyribonucleotide triphosphate metabolism in cancer and metabolic disease","volume":"9","author":"Buj","year":"2018","journal-title":"Front Endocrinol"},{"key":"2024050214014116200_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-015-0446-6","article-title":"Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications","volume":"14","author":"Kohnken","year":"2015","journal-title":"Mol Cancer"},{"key":"2024050214014116200_bib19","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/nar\/gkv047","article-title":"Regulation of mammalian nucleotide metabolism and biosynthesis","volume":"43","author":"Lane","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2024050214014116200_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2009.01.002","article-title":"The molecular determinants of de novo nucleotide biosynthesis in cancer cells","volume":"19","author":"Tong","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"2024050214014116200_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"2024050214014116200_bib22","first-page":"13","article-title":"Detection of mycoplasma contaminations","volume":"290","author":"Uphoff","year":"2005","journal-title":"Methods Mol Biol"},{"key":"2024050214014116200_bib23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat Protoc"},{"key":"2024050214014116200_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","article-title":"An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis","volume":"162","author":"Birsoy","year":"2015","journal-title":"Cell"},{"key":"2024050214014116200_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol"},{"key":"2024050214014116200_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2024050214014116200_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/bioinformatics\/btr709","article-title":"Robust rank aggregation for gene list integration and meta-analysis","volume":"28","author":"Kolde","year":"2012","journal-title":"Bioinformatics"},{"key":"2024050214014116200_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/metabo11050313","article-title":"Redox metabolism measurement in mammalian cells and tissues by LC-MS","volume":"11","author":"Petrova","year":"2021","journal-title":"Metabolites"},{"key":"2024050214014116200_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2024050214014116200_bib30","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J Proteome Res"},{"key":"2024050214014116200_bib31","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2024050214014116200_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2020.10.017","article-title":"Functional genomics in vivo reveal metabolic dependencies of pancreatic cancer cells","volume":"33","author":"Zhu","year":"2021","journal-title":"Cell Metab"},{"key":"2024050214014116200_bib33","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"key":"2024050214014116200_bib34","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.celrep.2016.03.043","article-title":"MTAP deletions in cancer create vulnerability to targeting of the MAT2A\/PRMT5\/RIOK1 axis","volume":"15","author":"Marjon","year":"2016","journal-title":"Cell Rep"},{"key":"2024050214014116200_bib35","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1158\/0008-5472.CAN-20-0414","article-title":"MTAP deficiency-induced metabolic reprogramming creates a vulnerability to cotargeting de novo purine synthesis and glycolysis in pancreatic cancer","volume":"81","author":"Hu","year":"2021","journal-title":"Cancer Res"},{"key":"2024050214014116200_bib36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41467-022-29397-z","article-title":"MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers","volume":"13","author":"Alhalabi","year":"2022","journal-title":"Nat Commun"},{"key":"2024050214014116200_bib37","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1073\/pnas.78.2.1219","article-title":"Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme","volume":"78","author":"Kamatani","year":"1981","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2024050214014116200_bib38","first-page":"5653","article-title":"Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells","volume":"56","author":"Hori","year":"1996","journal-title":"Cancer Res"},{"key":"2024050214014116200_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3727\/0965040041292332","article-title":"Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells","volume":"14","author":"Li","year":"2004","journal-title":"Oncol Res"},{"key":"2024050214014116200_bib40","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.18632\/aging.202640","article-title":"Suppression of p16 alleviates the senescence-associated secretory phenotype","volume":"13","author":"Buj","year":"2021","journal-title":"Aging"},{"key":"2024050214014116200_bib41","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/s41388-020-1354-9","article-title":"Senescence as a therapeutically relevant response to CDK4\/6 inhibitors","volume":"39","author":"Wagner","year":"2020","journal-title":"Oncogene"},{"key":"2024050214014116200_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-800223-0.00004-9","article-title":"Biology of the major facilitative folate transporters SLC19A1 and SLC46A1","volume":"73","author":"Hou","year":"2014","journal-title":"Curr Top Membr"},{"key":"2024050214014116200_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/bjc.1971.38","article-title":"The variability of individual tolerance to methotrexate in cancer patients","volume":"25","author":"Hansen","year":"1971","journal-title":"Br J Cancer"},{"key":"2024050214014116200_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0165-4608(95)00157-3","article-title":"Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines","volume":"86","author":"Zhang","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"2024050214014116200_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.clindermatol.2012.08.016","article-title":"Chemotherapy in the management of advanced cutaneous malignant melanoma","volume":"31","author":"Luke","year":"2013","journal-title":"Clin Dermatol"},{"key":"2024050214014116200_bib46","first-page":"501","article-title":"Alteration of CDKN2\/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents","volume":"17","author":"Iwadate","year":"2000","journal-title":"Int J Oncol"},{"key":"2024050214014116200_bib47","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Cell"},{"key":"2024050214014116200_bib48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"2024050214014116200_bib49","doi-asserted-by":"crossref","first-page":"101030","DOI":"10.1016\/j.cpsurg.2021.101030","article-title":"Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies","volume":"59","author":"Newcomer","year":"2022","journal-title":"Curr Probl Surg"},{"key":"2024050214014116200_bib50","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.3390\/cancers15184631","article-title":"Insights into melanoma clinical practice: a perspective for future research","volume":"15","author":"Lam","year":"2023","journal-title":"Cancers"},{"key":"2024050214014116200_bib51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/cup.13721","article-title":"p16 range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma","volume":"47","author":"Oaxaca","year":"2020","journal-title":"J Cutan Pathol"},{"key":"2024050214014116200_bib52","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1158\/0008-5472.CAN-18-0814","article-title":"Specific Targeting of MTAP-deleted tumors with a combination of 2'-Fluoroadenine and 5'-Methylthioadenosine","volume":"78","author":"Tang","year":"2018","journal-title":"Cancer Res"},{"key":"2024050214014116200_bib53","doi-asserted-by":"crossref","first-page":"e135071","DOI":"10.1172\/jci.insight.135071","article-title":"IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex","volume":"5","author":"Valvezan","year":"2020","journal-title":"JCI insight"},{"key":"2024050214014116200_bib54","doi-asserted-by":"crossref","first-page":"e78641","DOI":"10.1371\/journal.pone.0078641","article-title":"RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs","volume":"8","author":"Robinson","year":"2013","journal-title":"PLoS One"},{"key":"2024050214014116200_bib55","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-022-30375-8","article-title":"CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer","volume":"13","author":"Filippone","year":"2022","journal-title":"Nat Commun"},{"key":"2024050214014116200_bib56","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/1078-0432.CCR-07-2065","article-title":"Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure","volume":"14","author":"Derenzini","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2024050214014116200_bib57","doi-asserted-by":"crossref","first-page":"55848","DOI":"10.18632\/oncotarget.19862","article-title":"Loss of p16(INK4A) stimulates aberrant mitochondrial biogenesis through a CDK4\/Rb-independent pathway","volume":"8","author":"Tyagi","year":"2017","journal-title":"Oncotarget"},{"key":"2024050214014116200_bib58","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41556-022-00965-1","article-title":"Nucleotide imbalance decouples cell growth from cell proliferation","volume":"24","author":"Diehl","year":"2022","journal-title":"Nat Cell Biol"},{"key":"2024050214014116200_bib59","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.2147\/OTT.S116387","article-title":"Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells","volume":"9","author":"Xie","year":"2016","journal-title":"Onco Targets Ther"},{"key":"2024050214014116200_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/emmm.200900040","article-title":"Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2","volume":"1","author":"Martin","year":"2009","journal-title":"EMBO Mol Med"},{"key":"2024050214014116200_bib61","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.chembiol.2023.08.007","article-title":"Screening in serum-derived medium reveals differential response to compounds targeting metabolism","volume":"30","author":"Abbott","year":"2023","journal-title":"Cell Chem Biol"},{"key":"2024050214014116200_bib62","article-title":"Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions","author":"Kyle","year":"2023","journal-title":"bioRxiv"},{"key":"2024050214014116200_bib63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1359-4117.2002.01049.x","article-title":"Severe folate restriction results in depletion of and alteration in the composition of the intracellular folate pool, moderate sensitization to methotrexate and trimetrexate, upregulation of endogenous DHFR activity, and overexpression of metallothionein II and folate receptor alpha that, upon folate repletion, confer drug resistance to CHL cells","volume":"2","author":"Zhu","year":"2002","journal-title":"J Exp Ther Oncol"},{"key":"2024050214014116200_bib64","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1158\/1078-0432.1294.11.3","article-title":"Loss of reduced folate carrier function and folate depletion result in enhanced pemetrexed inhibition of purine synthesis","volume":"11","author":"Zhao","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2024050214014116200_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"2024050214014116200_bib66","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"2024050214014116200_bib67","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"2024050214014116200_bib68","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1509660","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Valsecchi","year":"2015","journal-title":"N Engl J Med"},{"key":"2024050214014116200_bib69","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"2024050214014116200_bib70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1200\/JCO.2017.72.2850","article-title":"Nivolumab plus ipilimumab in patients with advanced melanoma: updated survival, response, and safety data in a phase I dose-escalation study","volume":"36","author":"Callahan","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024050214014116200_bib71","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s43018-020-0106-7","article-title":"Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors","volume":"1","author":"Keshet","year":"2020","journal-title":"Nat Cancer"},{"key":"2024050214014116200_bib72","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cell.2018.07.019","article-title":"Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures","volume":"174","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"2024050214014116200_bib73","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-19-0433","article-title":"The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy","volume":"25","author":"Schaer","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2024050214014116200_bib74","doi-asserted-by":"crossref","first-page":"927265","DOI":"10.3389\/fimmu.2022.927265","article-title":"Combination approaches to target PD-1 signaling in cancer","volume":"13","author":"Moore","year":"2022","journal-title":"Front Immunol"},{"key":"2024050214014116200_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/cancers14020293","article-title":"The renaissance of cyclin dependent kinase inhibitors","volume":"14","author":"Ettl","year":"2022","journal-title":"Cancers"},{"key":"2024050214014116200_bib76","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2147\/OTT.S240655","article-title":"Combination strategies of checkpoint immunotherapy in metastatic breast cancer","volume":"13","author":"Liu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"2024050214014116200_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccell.2018.03.023","article-title":"CDK4\/6 inhibitors: the mechanism of action may not be as simple as once thought","volume":"34","author":"Klein","year":"2018","journal-title":"Cancer Cell"},{"key":"2024050214014116200_bib78","doi-asserted-by":"crossref","first-page":"102016","DOI":"10.1016\/j.isci.2020.102016","article-title":"Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype","volume":"24","author":"Hao","year":"2021","journal-title":"iScience"},{"key":"2024050214014116200_bib79","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"key":"2024050214014116200_bib80","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","article-title":"Senescence rewires microenvironment sensing to facilitate antitumor immunity","volume":"13","author":"Chen","year":"2023","journal-title":"Cancer Discov"},{"key":"2024050214014116200_bib81","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular senescence is immunogenic and promotes antitumor immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov"},{"key":"2024050214014116200_bib82","doi-asserted-by":"crossref","first-page":"e2117754119","DOI":"10.1073\/pnas.2117754119","article-title":"Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer","volume":"119","author":"Paffenholz","year":"2022","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2024050214014116200_bib83","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2326-6066.CIR-23-0051","article-title":"Senescence and immunotherapy: redundant immunomodulatory pathways promote resistance","volume":"11","author":"Oesterreich","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"2024050214014116200_bib84","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s43018-022-00466-y","article-title":"Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80","volume":"3","author":"Shahbandi","year":"2022","journal-title":"Nat Cancer"},{"key":"2024050214014116200_bib85","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat Rev Cancer"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0450\/3442722\/crc-23-0450.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/5\/1174\/3450126\/crc-23-0450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/5\/1174\/3450126\/crc-23-0450.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T10:03:09Z","timestamp":1714644189000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/5\/1174\/745132\/De-Novo-Purine-Metabolism-is-a-Metabolic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0450","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7214709","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7214709.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2023.07.15.549149","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25738353.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738389","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738356.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738350.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738359.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738380","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738365.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738371.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738368.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738398","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738362.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738386","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738374","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738350","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738392","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738377.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738401.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738380.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738383.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738374.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738401","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738395.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738386.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738389.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738377","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738398.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738353","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738395","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738392.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738383","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25738371","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}